title: Prolonged time to progression with fulvestrant for metastatic breast cancer.
authors.affiliation: Fundação Antônio Prudente, Hospital do Câncer A. C. Camargo, Rua Prof Antônio Prudente, Liberdade, São Paulo, SP, 01509-900, Brazil. celso.mello@hcancer.org.br
authors.forename: Celso A L
authors.initials: CA
authors.lastname: Mello
authors.forename: Ludmilla T D
authors.initials: LT
authors.lastname: Chinen
authors.forename: Samantha Cabral Severino
authors.initials: SC
authors.lastname: da Silva
authors.forename: Carolina
authors.initials: C
authors.lastname: do Nascimento Matias
authors.forename: Carlos Frederico
authors.initials: CF
authors.lastname: Benevides
authors.forename: Daniel Luiz
authors.initials: DL
authors.lastname: Gimenes
authors.forename: Marcello F
authors.initials: MF
authors.lastname: Fanelli
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D015331:Cohort Studies; D018450:Disease Progression; D018572:Disease-Free Survival; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D000077267:Fulvestrant; D018734:Genes, erbB-2; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D011960:Receptors, Estrogen / Q000096:biosynthesis / Q000235:genetics; D011980:Receptors, Progesterone / Q000096:biosynthesis / Q000235:genetics; D012189:Retrospective Studies
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D000077267:Fulvestrant; D004958:Estradiol